Viscosupplementation is a method in which a thick fluid called hyaluronate is injected into the knee joint. There are no remedies for osteoarthritis, so viscosupplementation will not counteract osteoarthritis of the knee. However, it is claimed that hyaluronate helps in improving the lubricating properties of the synovial fluid, lessen the pain from osteoarthritis of the knee, improves mobility, and provide a higher and more convenient level of activity. Viscosupplementation is a minimally invasive procedure which involves injection of gel-like substance. Currently hyaluronate injections are only approved viscosupplementation therapy of osteoarthritis of the knee. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues.
MARKET DYNAMICS
Viscosupplementation market is anticipated to grow in the forecast period owing to driving factors such as rising number of increasing geriatric population, increasing demand for minimally invasive surgical procedures, high patient awareness about new drugs. Moreover and devices for the treatment of osteoarthritis and rising obese population globally, rising investments by major players for the growing demand are also offering opportunities in the market growth during the forecast period.
MARKET SCOPE
The "Global Viscosupplementation Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of viscosupplementation market with detailed market segmentation by course of treatment, anatomy, end user, and geography. The global viscosupplementation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading viscosupplementation market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global viscosupplementation market is segmented on the basis of course of treatment, anatomy and end user. Based on course of treatment, the market is segmented as Single Injection and multiple injection. Based on Anatomy, the market is segmented as Knee Osteoarthritis, Hip Osteoarthritis, Ankle Osteoarthritis and Shoulder Osteoarthritis. On the basis of end user, the global viscosupplementation market is segmented into hospitals, clinics, and ambulatory service centers.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global viscosupplementation market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The viscosupplementation market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting viscosupplementation market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the viscosupplementation market in these regions.
MARKET PLAYERS
The report covers key developments in the viscosupplementation market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from viscosupplementation market are anticipated to lucrative growth opportunities in the future with the rising demand for viscosupplementation in the global market. Below mentioned is the list of few companies engaged in the viscosupplementation market.
The report also includes the profiles of key viscosupplementation market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Bioventus Inc.
- Anika Therapeutics
- Seikagaku Corporation
- Zimmer Biomet
- Smith & Nephew PLC
- Ferring B.V.
- Lifecore Biomedical, LLC (Landec)
- Salix Pharmaceuticals
- Fidia Farmaceutici S.P.A
- LG Life Sciences Ltd.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.